Fda Alerts Article Listing | RxWiki

FDA Alerts

FDA Approves New Drug for Cushing’s Syndrome

Korlym ( mifepristone ) was approved by the U.S. Food and Drug Administration to control high blood sugar levels (hyperglycemia) in adults with endogenous Cushing’s syndrome.

REFINE

medications
- - (-) Remove Korlym filter Korlym
conditions
- - (-) Remove Gastrointestinal filter Gastrointestinal
    (-) Remove Liver Disease filter Liver Disease
    (-) Remove Metabolic Defects filter Metabolic Defects
  - Patient Safety Education (1) Apply Patient Safety Education filter